- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04289350
Day to Day Variation in Fetal Heart Rate Variability ((FHRV))
November 1, 2022 updated by: University of Aarhus
Day to Day Variation in Fetal Heart Rate Variability Based on Fetal Electrocardiography (FECG), in a Standardized Setting: A Cohort Study
This study evaluates the day-to-day variation in fetal heart rate variability based on non-invasive fetal-ECG (NI-FECG).
Furthermore, the effect of fetal movements on fetal heart rate variability will be assessed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
44
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Aarhus N
-
Aarhus, Aarhus N, Denmark, 8200
- Department of Obstetrics and Gynecology. Aarhus Unive
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Healthy singleton pregnant women.
Danish.
Description
Inclusion Criteria:
- Healthy singleton pregnant women with an expected healthy fetus
Exclusion Criteria:
- fetal malformations, multiple pregnancy, obstetric complications, maternal chronic disease and labor. Low birth weight or malformation diagnosed at birth.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Root mean square of successive inter beat interval differences (RMSSD)
Time Frame: 1/8-2020
|
Time domain analysis
|
1/8-2020
|
|
Standard deviation of normal to normal inter beat interval (SDNN)
Time Frame: 1/8-2020
|
Time domain analysis
|
1/8-2020
|
|
High frequency power (HF-power)
Time Frame: 1/8-2020
|
Spectral analysis
|
1/8-2020
|
|
Low frequency power (LF-power)
Time Frame: 1/8-2020
|
spectral analysis
|
1/8-2020
|
|
Low frequency power/High frequency power (LF/HF)
Time Frame: 1/8-2020
|
Spectral analysis
|
1/8-2020
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2018
Primary Completion (Actual)
July 1, 2020
Study Completion (Actual)
July 1, 2020
Study Registration Dates
First Submitted
February 20, 2020
First Submitted That Met QC Criteria
February 26, 2020
First Posted (Actual)
February 28, 2020
Study Record Updates
Last Update Posted (Actual)
November 2, 2022
Last Update Submitted That Met QC Criteria
November 1, 2022
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- fHRV_2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fetal Growth Retardation
-
Nantes University HospitalTerminatedIntra Uterine Growth RetardationFrance
-
amera mohamedUnknownThe Relationship Between Second Trimester Placental Growth Factor Level and Fetal Growth RestrictionIntra Uterine Growth RetardationEgypt
-
Johns Hopkins UniversityWithdrawnFetal Growth Retardation | Intrauterine Growth Restriction | Intrauterine Growth Retardation | Fetal Growth Restriction
-
Poitiers University HospitalCompletedIntrauterine Growth Retardation (IUGR)France
-
PfizerCompletedGrowth Disorders | Intrauterine Growth RetardationFrance
-
Van Bölge Eğitim ve Araştırma HastanesiCompletedIntrauterine RetardationTurkey
-
Ain Shams Maternity HospitalCompletedFasting | Fetal Growth Retardation, Antenatal (Disorder)
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A., GenevaCompletedChildren Born With Serious Intra-uterine Growth Retardation
-
University Hospital, GrenobleRegistre de Handicap de l'Enfant et Observatoire Périnatal (RHEOP) Isère,... and other collaboratorsUnknownStillbirth | Infant, Small for Gestational Age | Intrauterine Growth RetardationFrance
-
University of South FloridaCompleted
Clinical Trials on fetal heart rate variability
-
University of AarhusAarhus University Hospital; Aalborg University; Snedkermester Sophus Jacobsen... and other collaboratorsCompleted
-
University of AarhusAarhus University Hospital; Snedkermester Sophus Jacobsen and hustru Astrid... and other collaboratorsUnknown
-
University Hospital, LilleCompletedObstetric LaborFrance
-
Centre Hospitalier Universitaire de NīmesRecruitingSurgery--ComplicationsFrance
-
University of California, San DiegoUnknown
-
University Hospital Bispebjerg and FrederiksbergRecruitingHeart FailureDenmark
-
University of Sao PauloActive, not recruitingReliability and ValidityBrazil
-
University of IowaCompletedAcute Coronary SyndromeUnited States
-
University of Southern CaliforniaNational Institute of Mental Health (NIMH)Recruiting